Isaacs’ syndrome-possible etiopathogenesis and clinical aspects: a case report
DOI:
https://doi.org/10.18203/2320-6012.ijrms20240227Keywords:
IS, MRI, Plasmapheresis, Anti-TPOAbstract
Isaacs’ syndrome (IS) is a rare condition which is characterized by peripheral nerve hyperexcitability which is due to continuous motor activity. The exact etiology for this condition is unknown yet there are several etiopathologies like autoimmune, genetic, or hereditary which can be an etiology for the IS. In our case report the likely etiology is autoimmune. Its clinical feature includes fasciculation, myokymia, and hyperhidrosis. To confirm the diagnosis mostly imaging methods of examination are performed like MRI, ultrasound, and EMG. In our patient MRI and EMG examination was performed. There are no particular therapeutic treatments that can help in this condition only symptomatic treatment can be delivered. Plasma exchange has a promising outcome for a momentary. In our case report, we propose the possible etiology of the condition.
References
Patel AN, Parth KP, Jaydip D, Srivikram MS, Katie O, Reddy PJ. A Rare Phenomenon of Isaacs Syndrome: A Case Report. Cureus. 2023;15(1):1-6.
Hart IK, Maddison P, Newsom-Davis J, Vincent A, Mills KR. Phenotypic variants of autoimmune peripheral nerve hyperexcitability. Brain. 2002;125(pt8):1887-95.
Bashford J, Chan WK, Coutinho E, Norwood F, Mills K, Shaw CE et al. Demystifying the spontaneous phenomena of motor hyperexcitability. Clin Neurophysiol. 2021;132(8):1830-44.
Ahmed A, Simmons Z. Isaacs syndrome: A review. Muscle Nerve. 2015;52(1):5-12.
Zimoń M, Jonathan B, Leonardo A-S, Els DV, Jelena N, Yesim P et al. Loss-of-function mutations in HINT1 cause axonal neuropathy with neuromyotonia. Nat Genet. 2012;44(10):1080-3.
Caetano JS, Carmen C, Jonathan B, Madgalena Z, Margarida V, Jorge S et al. Autosomal recessive axonal neuropathy with neuromyotonia: A rare entity. Pediatr Neurol. 2014;50(1):104-7.
Aminkeng, F. HINT1 mutations define a novel disease entity - autosomal recessive axonal neuropathy with neuromyotonia. Clin Genet. 2013;83(1):31-2.
Irani SR, Sian A, Patrick W, Kleopas AK, Philippa P, Luigi Z et al. Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan’s syndrome and acquired neuromyotonia. Brain. 2010;133(9):2734-48.
Nakazato T, Yukiko T, Kazuaki K, Yu-Ichi N, Yasunobu H, Kazuo Y et al. Isaacs syndrome: A slow potassium channelopathy caused by autoantibodies? Clin Neurophysiol. 2018;129(5):956-8.
Epure DA, Ioghen MR, Roza E, Teleanu RI. A case report of morvan syndrome, the unique clinical pattern of a rare disease. Rom J Neurol Rev Rom Neurol. 2020;19(1):54-6.
Komakulu S, Pranjal G, Abhishek A, Animesh D, Awadh KP, Achal KS et al. A Case of Hemi-Isaac’s Syndrome. Mov Disord Clin Pract. 2021;8(7):1126-8.
Song J, Sisi J, Chao Q, Jun L, Xiangyang Q, Kai Q et al. Isaacs syndrome with CASPR2 antibody: A series of three cases. J Clin Neurosci. 2017;41:63-6.
Roy SS, Kapoor R, Saini R, Goel N. ISAAC syndrome. SlideShare. 2022;13:4-6.
Dhand UK. Isaacs’ syndrome: Clinical and electrophysiological response to gabapentin. Muscle Nerve. 2006;34(5):646-50.
Çelebi E. Section I. Narrat Travel Eur Asia, Africa Seventeenth Century. 2015;5-5.
Deymeer F, Oge AE, Serdaroğlu P, Yazici J, Ozdemir C, Baslo A. The use of botulinum toxin in localizing neuromyotonia to the terminal branches of the peripheral nerve. Muscle Nerve. 1998;21(5):643-6.
Newsom-davis J, Mills KR. Immunological associations of acquired neuromyotonia (Isaacs’ syndrome): Report of five cases and literature review. Brain. 1993;116(pt2):453-69.
Saeed A, Saeed R, Mohammed Z, Hamid S. A 72 Year Old Man with Isaacs Syndrome: A Rare Entity with Different Outcomes. J Neurobehav Sci. 2016;3(2):116.
Takahashi H, Masahiro M, Yukari S, Sonoko M, Setsu S, Takamichi H et al. Development of Isaacs’ syndrome following complete recovery of voltage-gated potassium channel antibody-associated limbic encephalitis. J Neurol Sci. 2008;275(1-2):185-7.
Meyniel C, Ollivier Y, Hamidou M, Péréon Y, Derkinderen P. Dramatic improvement of refractory Isaacs’ syndrome after treatment with dronabinol. Clin Neurol Neurosurg. 2011;113(4):323-4.
Horiuchi K, Kudo A, Inoue T, Fujii S, Oshima Y. Rituximab Was Effective in Relieving Symptoms of Isaacs Syndrome: A Case Report. Cureus. 2022;14(10):1-5.
Pulkes T, Dejthevaporn C, Apiwattanakul M, Papsing C, Hanna MG. Paroxysmal neuromyotonia: A new sporadic channelopathy. Neuromuscul Disord. 2012;22(6):479-82.
França MC, Schmutzler KMR, Garibaldi SG, Zanardi VA, Nucci A. Bilateral substantia nigra involvement in vaccine-associated poliomyelitis. Neurology. 2006;66(10):1597-8.
Merchut MP. Management of voltage-gated potassium channel antibody disorders. Neurol Clin. 2010;28(4):941-59.
Skeie GO, Apostolski S, Evoli A, Gilhus NE, Illa I, Harms L et al. Guidelines for treatment of autoimmune neuromuscular transmission disorders. Eur J Neurol. 2010;17(7):893-902.
Black AJ, McLeod HL, Capell HA, Powrie RH, Matowe LK, Pritchard SC et al. Thiopurine methyltransferase genotype predicts therapy-limiting severe toxicity from azathioprine. Ann Intern Med. 1998;129(9):716-8.
Slanař O, Chalupná P, Novotný A, Bortlík M, Krska Z, Lukás M. Fatal myelotoxicity after azathioprine treatment. Nucleosides Nucleotides Nucleic Acids. 2008;27(6):661-5.
Warmolts JR, Mendell JR. Neurotonia: Impulse‐induced repetitive discharges in motor nerves in peripheral neuropathy. Ann Neurol. 1980;7(3):245-50.
Tanosaki M, Baba M, Miura H, Matsunaga M, Arimura,K. Reversible F-wave hyperexcitability associated with antibodies to potassium channels in Isaacs’ syndrome. Eur J Neurol. 1999;6(1):95-8.
Vernino S, Lennon VA. Ion channel and striational antibodies define a continuum of autoimmune neuromuscular hyperexcitability. Muscle Nerve. 2002;26(5):702-7.
Rana SS, Ramanathan RS, Small G, Adamovich B. Paraneoplastic Isaacs’ syndrome: A case series and review of the literature. J Clin Neuromuscul Dis. 2012;13(4):228-33.
